Recruitment momentum for EMVision’s pivotal clinical trial for the emu point-of-care brain scanner is building, with seven ...

Here we highlight a subset of our preferred stocks from the screener. Overview: EMVision Medical Devices Ltd focuses on the research, development, and commercialization of neurodiagnostic technology ...

Following a long-standing relationship, Keysight Technologies has acquired a strategic equity stake in EMVision, providing the Aussie Medtech with a fully funded path to market SYDNEY--(BUSINESS WIRE) ...

It hasn't been the best quarter for EMVision Medical Devices Ltd (ASX:EMV) shareholders, since the share price has fallen 13% in that time. But over five years returns have been remarkably great.

SYDNEY--(BUSINESS WIRE)--EMVision (ASX: EMV), an Australian medical device company focused on the development and commercialisation of innovative portable brain scanning technology, has today unveiled ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after ...

EMVision updates progress on its pivotal trial supporting FDA de novo clearance for the emu brain scanner and its continuous innovation study. Don't miss out on the headlines from Stockhead. Followed ...

EMVision is advancing its AI-driven stroke diagnostics with promising new data showing enhanced performance of its ‘ischemia or not’ algorithm. Data being presented at 11th European Stroke ...

EMVision updates progress on its pivotal trial supporting FDA de novo clearance for the emu brain scanner and its continuous innovation study. EMVision Medical Devices (ASX:EMV) today provided an ...